FDA Orange Book · active-ingredient family
Glycopyrrolate
Glycopyrrolate: 9 brands, 59 generics; first approved Jun 24, 1983; generic available.
Generic availableHas discontinued products
Generic status & protection
Generic available: 59 ANDA applications approved.
Earliest patent expiry
Brands (NDA)
9
Generics (ANDA)
59
Listed patents
11
Next patent expiry
Aug 16, 2026
2 mo ago
Brand (NDA) products
Originator applications
- GLYCOPYRROLATERLDRSFRESENIUS KABI USANDA 2149192022
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.6MG/3ML (0.2MG/ML) SOLUTION INTRAMUSCULAR, INTRAVENOUS Rx - - DARTISLA ODTRLDEDENBRIDGE PHARMSNDA 21501920212 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.7MG TABLET, ORALLY DISINTEGRATING ORAL Discontinued - 0.85MG TABLET, ORALLY DISINTEGRATING ORAL Discontinued - - GLYRX-PFRLDEXELA PHARMANDA 21099720184 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML (0.2MG/ML) SOLUTION INTRAMUSCULAR, INTRAVENOUS Discontinued - 0.4MG/2ML (0.2MG/ML) SOLUTION INTRAMUSCULAR, INTRAVENOUS Rx - 1MG/5ML (0.2MG/ML) SOLUTION INTRAMUSCULAR, INTRAVENOUS Rx - 0.6MG/3ML (0.2MG/ML) SOLUTION INTRAMUSCULAR, INTRAVENOUS Discontinued - - SUMITOMO PHARMA AMNDA 2084372017
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MCG/ML SOLUTION INHALATION Discontinued - - NOVARTISNDA 2079232015
Approved strengths under this FDA application. Strength Dosage form Route Status TE 15.6MCG/INH POWDER INHALATION Discontinued - - MERZ PHARMSNDA 0225712010
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1MG/5ML SOLUTION ORAL Rx AA - ROBINULRLDHIKMANDA 017558-
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML INJECTABLE INJECTION Rx AP - ROBINULRLDCASPER PHARMA LLCNDA 012827-2 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1MG TABLET ORAL Rx AA 2MG TABLET ORAL Rx AA - ROBINS AHNDA 014764-
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML INJECTABLE INJECTION Discontinued -
Generic (ANDA) products (59)
Abbreviated applications
- GLYCOPYRROLATEQUAGENANDA 2169102026
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1MG/5ML SOLUTION ORAL Rx AA - GLYCOPYRROLATEBIONPHARMAANDA 2200622025
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1MG/5ML SOLUTION ORAL Rx AA - GLYCOPYRROLATEAJENAT PHARMSANDA 2192672025
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1MG/5ML SOLUTION ORAL Rx AA - GLYCOPYRROLATEMSNANDA 2160842025
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1MG/5ML SOLUTION ORAL Rx AA - GLYCOPYRROLATEAUROBINDO PHARMA LTDANDA 2148472024
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1MG/5ML SOLUTION ORAL Rx AA - GLYCOPYRROLATESCIEGEN PHARMSANDA 2162972024
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1MG/5ML SOLUTION ORAL Rx AA - GLYCOPYRROLATECHARTWELL RXANDA 2163682024
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1MG/5ML SOLUTION ORAL Rx AA - GLYCOPYRROLATEGRANULESANDA 2147352024
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1MG/5ML SOLUTION ORAL Rx AA - GLYCOPYRROLATEQUAGENANDA 21269620242 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1MG TABLET ORAL Rx AA 2MG TABLET ORAL Rx AA - GLYCOPYRROLATEMANKIND PHARMAANDA 2173542023
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML INJECTABLE INJECTION Discontinued - - GLYCOPYRROLATELUPINANDA 2136552023
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML INJECTABLE INJECTION Discontinued - - GLYCOPYRROLATEOMNIVIUM PHARMSANDA 2128712022
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML INJECTABLE INJECTION Rx AP - GLYCOPYRROLATEALEMBICANDA 2146352022
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML INJECTABLE INJECTION Rx AP - GLYCOPYRROLATEAMNEALANDA 2153332022
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML INJECTABLE INJECTION Rx AP - GLYCOPYRROLATEANNORA PHARMAANDA 2136982022
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1MG/5ML SOLUTION ORAL Rx AA - GLYCOPYRROLATESUVEN PHARMSANDA 2124672022
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1MG/5ML SOLUTION ORAL Rx AA - GLYCOPYRROLATEZYDUS PHARMSANDA 2142132021
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML INJECTABLE INJECTION Discontinued - - GLYCOPYRROLATENIVAGENANDA 2125912021
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML INJECTABLE INJECTION Rx AP - GLYCOPYRROLATEPH HEALTHANDA 2044382021
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1MG/5ML SOLUTION ORAL Rx AA - GLYCOPYRROLATEMEITHEALANDA 2128022021
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML INJECTABLE INJECTION Rx AP - GLYCOPYRROLATEXIROMEDANDA 2122272021
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML INJECTABLE INJECTION Discontinued - - GLYCOPYRROLATEACCORD HLTHCAREANDA 2132382020
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML INJECTABLE INJECTION Rx AP - GLYCOPYRROLATESAGENTANDA 2100832020
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML INJECTABLE INJECTION Rx AP - GLYCOPYRROLATEAPOTEXANDA 2102462019
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML INJECTABLE INJECTION Discontinued - - GLYCOPYRROLATEGLANDANDA 2126122019
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML INJECTABLE INJECTION Rx AP - GLYCOPYRROLATESANDOZANDA 2113342019
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML INJECTABLE INJECTION Rx AP - GLYCOPYRROLATECAPLINANDA 2117052019
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML INJECTABLE INJECTION Rx AP - GLYCOPYRROLATEALEMBICANDA 20365720182 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1MG TABLET ORAL Rx AA 2MG TABLET ORAL Rx AA - GLYCOPYRROLATEEUGIA PHARMAANDA 2102442018
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML INJECTABLE INJECTION Discontinued - - GLYCOPYRROLATEFRESENIUS KABI USAANDA 2090242018
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML INJECTABLE INJECTION Rx AP - GLYCOPYRROLATEPRINSTON INCANDA 2109272018
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML INJECTABLE INJECTION Rx AP - GLYCOPYRROLATEPIRAMAL CRITICALANDA 2108422018
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML INJECTABLE INJECTION Rx AP - GLYCOPYRROLATEFRESENIUS KABI USAANDA 2093282017
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML INJECTABLE INJECTION Rx AP - GLYCOPYRROLATESOMERSET THERAPS LLCANDA 2076392017
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML INJECTABLE INJECTION Rx AP - GLYCOPYRROLATEAMNEALANDA 2089732017
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML INJECTABLE INJECTION Rx AP - GLYCOPYRROLATEAPPCOANDA 20720120172 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1MG TABLET ORAL Rx AA 2MG TABLET ORAL Rx AA - GLYCOPYRROLATENATCOANDA 09141320162 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1MG TABLET ORAL Rx AA 2MG TABLET ORAL Rx AA - GLYCOPYRROLATEREGCON HOLDINGSANDA 09118220142 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1MG TABLET ORAL Rx AA 2MG TABLET ORAL Rx AA - GLYCOPYRROLATEAUROBINDO PHARMAANDA 20267520132 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1MG TABLET ORAL Rx AA 2MG TABLET ORAL Rx AA - GLYCOPYRROLATEVELZEN PHARMA PVTANDA 09019520122 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1MG TABLET ORAL Rx AA 2MG TABLET ORAL Rx AA - GLYCOPYRROLATERSLGM PHARMAANDA 0915222012
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.5MG TABLET ORAL Rx - - GLYCOPYRROLATEOXFORD PHARMSANDA 09002020112 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1MG TABLET ORAL Rx AA 2MG TABLET ORAL Rx AA - GLYCOPYRROLATERSHIKMA FARMACEUTICAANDA 0909632011
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML INJECTABLE INJECTION Rx AP - GLYCOPYRROLATESUN PHARM INDS LTDANDA 04084420092 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1MG TABLET ORAL Rx AA 2MG TABLET ORAL Rx AA - GLYCOPYRROLATEHIKMA INTL PHARMSANDA 04083620092 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1MG TABLET ORAL Discontinued - 2MG TABLET ORAL Discontinued - - GLYCOPYRROLATERISINGANDA 04082120082 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1MG TABLET ORAL Rx AA 2MG TABLET ORAL Rx AA - GLYCOPYRROLATECHARTWELL RXANDA 04084720082 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1MG TABLET ORAL Rx AA 2MG TABLET ORAL Rx AA - GLYCOPYRROLATERSPH HEALTHANDA 04065320062 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1MG TABLET ORAL Rx AA 2MG TABLET ORAL Rx AA - GLYCOPYRROLATECHARTWELL RXANDA 04056820042 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1MG TABLET ORAL Discontinued - 2MG TABLET ORAL Discontinued - - GLYCOPYRROLATETEVA PARENTERALANDA 0811691991
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML INJECTABLE INJECTION Discontinued - - GLYCOPYRROLATEHOSPIRAANDA 0893931988
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML INJECTABLE INJECTION Discontinued - - GLYCOPYRROLATEAM REGENTANDA 0893351986
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML INJECTABLE INJECTION Rx AP - GLYCOPYRROLATEABRAXIS PHARMANDA 0884751984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML INJECTABLE INJECTION Discontinued - - GLYCOPYRROLATEWATSON LABSANDA 0869471983
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.2MG/ML INJECTABLE INJECTION Discontinued - - GLYCOPYRROLATEWATSON LABSANDA 085562-
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1MG TABLET ORAL Discontinued - - GLYCOPYRROLATEWATSON LABSANDA 086902-
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1MG TABLET ORAL Discontinued - - GLYCOPYRROLATEWATSON LABSANDA 085563-
Approved strengths under this FDA application. Strength Dosage form Route Status TE 2MG TABLET ORAL Discontinued - - GLYCOPYRROLATEWATSON LABSANDA 086178-
Approved strengths under this FDA application. Strength Dosage form Route Status TE 2MG TABLET ORAL Discontinued - - GLYCOPYRROLATEWATSON LABSANDA 086900-
Approved strengths under this FDA application. Strength Dosage form Route Status TE 2MG TABLET ORAL Discontinued -
Patent & exclusivity timeline
Protection horizon
Patent expiryExclusivity endToday
Listed patents
Orange Book patent file
| Patent | Expires | In | Type |
|---|---|---|---|
| 11278683 | 2 mo ago | Product | |
| 8479730 | in 2 yr | Product | |
| 8182838 | in 2 yr | Product | |
| 9265900 | in 2 yr 2 mo | Product | |
| 10940110 | in 2 yr 5 mo | ProductU-1773 | |
| 9789270 | in 4 yr 1 mo | Product | |
| 9168556 | in 5 yr 11 mo | Product | |
| 9604018 | in 6 yr 8 mo | Product | |
| 10376661 | in 9 yr | Product | |
| 10688518 | in 10 yr 2 mo | Product | |
| 10744277 | in 10 yr 3 mo | ProductU-2941 |
Approval history
FDA approval span
First approval
44 yr ago
Most recent approval
5 mo ago
Approvals span 1983–2026 across 68 FDA applications.
Brand (NDA) 913%
Generic (ANDA) 5987%
Glycopyrrolate: frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Related FDA reference tools
- FDA Purple BookLicensed biologics, biosimilars, interchangeables, BLA records, and exclusivity dates.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.
Assyro Intelligence
Ask anything about Glycopyrrolate
Cited answers from FDA, EMA, Health Canada, PubMed and ClinicalTrials.gov, in seconds. Free, no sign-up.
Evaluating for a team? Book a demo